BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Tanrıöver MD, Akar S, Türkçapar N, Karadağ Ö, Ertenli İ, Kiraz S. Vaccination recommendations for adult patients with rheumatic diseases. Eur J Rheumatol 2016;3:29-35. [PMID: 27708966 DOI: 10.5152/eurjrheum.2016.16100] [Cited by in Crossref: 14] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Shokouhi S, Hakamifard A. COVID-19 vaccine and corticosteroids: A challenging issue. Eur J Inflamm 2021;19:205873922110661. [DOI: 10.1177/20587392211066188] [Reference Citation Analysis]
2 Schwartz RA, Pradhan S, Murrell DF, Jafferany M, Olisova OY, Lomonosov KM, Lotti T, Goldust M. COVID-19 and immunosuppressive therapy in dermatology. Dermatol Ther 2020;33:e14140. [PMID: 32770592 DOI: 10.1111/dth.14140] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
3 Vecchié A, Del Buono MG, Mauro AG, Cremer PC, Imazio M, Klein AL, Abbate A, Dentali F, Bonaventura A. Advances in pharmacotherapy for acute and recurrent pericarditis. Expert Opinion on Pharmacotherapy. [DOI: 10.1080/14656566.2022.2054327] [Reference Citation Analysis]
4 Mason A, Anver H, Lwin M, Holroyd C, Faust SN, Edwards CJ. Lupus, vaccinations and COVID-19: What we know now. Lupus 2021;:9612033211024355. [PMID: 34134555 DOI: 10.1177/09612033211024355] [Reference Citation Analysis]
5 Seo YB, Moon SJ, Jeon CH, Song JY, Sung YK, Jeong SJ, Kwon KT, Kim ES, Kim JH, Kim HA, Park DJ, Park SH, Park JK, Ahn JK, Oh JS, Yun JW, Lee JH, Lee HY, Choi MJ, Choi WS, Choi YH, Choi JH, Heo JY, Cheong HJ, Lee SS. The Practice Guideline for Vaccinating Korean Patients with Autoimmune Inflammatory Rheumatic Disease. Infect Chemother 2020;52:252-80. [PMID: 32618150 DOI: 10.3947/ic.2020.52.2.252] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
6 Speeckaert R, Lambert J, Puig L, Speeckaert M, Lapeere H, De Schepper S, van Geel N. Vaccinations in Patients Receiving Systemic Drugs for Skin Disorders: What Can We Learn for SARS-Cov-2 Vaccination Strategies? Drugs R D 2021;21:341-50. [PMID: 34106430 DOI: 10.1007/s40268-021-00349-0] [Reference Citation Analysis]
7 Seo YB, Moon S, Jeon CH, Song JY, Sung Y, Jeong SJ, Kwon KT, Kim ES, Kim J, Kim H, Park D, Park S, Park JK, Ahn JK, Oh JS, Yun JW, Lee J, Lee HY, Choi MJ, Choi WS, Choi YH, Choi J, Heo JY, Cheong HJ, Lee S. The Practice Guideline for Vaccinating Korean Patients With Autoimmune Inflammatory Rheumatic Disease. J Rheum Dis 2020;27:182-202. [DOI: 10.4078/jrd.2020.27.3.182] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
8 Valim V, Machado KLLL, Miyamoto ST, Pinto AD, Rocha PCM, Serrano EV, Dinis VG, Gouvêa SA, Dias JGF, Campi-Azevedo AC, Teixeira-Carvalho A, Peruhype-Magalhães V, da Costa-Rocha IA, de Lima SMB, Miranda EH, Trindade GF, Maia MLS, Gavi MBRO, da Silva LB, Duque RH, Gianordoli APE, Casagrande TZ, Oliveira KG, Moura BCDM, Nicole-Batista F, Rodrigues LC, Clemente TB, Magalhães ES, Bissoli MF, Gouvea MDPG, Pinto-Neto LFDS, Costa CZ, Giovelli RA, Brandão LR, Polito ETL, Koehlert IO, Borjaille BP, Pereira DB, Dias LH, Merlo DL, Genelhu LFF, Pretti FZ, Giacomin MDS, Burian APN, Fantinato FFST, Pileggi GS, da Mota LMH, Martins-Filho OA. Planned Yellow Fever Primary Vaccination Is Safe and Immunogenic in Patients With Autoimmune Diseases: A Prospective Non-interventional Study. Front Immunol 2020;11:1382. [PMID: 32765496 DOI: 10.3389/fimmu.2020.01382] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
9 AlEnizi A, AlSaeid K, Alawadhi A, Hasan E, Husain EH, AlFadhli A, Ghanem A, Abutiban F, Ali Y, Al-Herz A, Mohammed K, Alkandari W, Aldei A, Alhajeri H, Dehrab A, Hayat S. Kuwait Recommendations on Vaccine Use in People with Inflammatory Rheumatic Diseases. Int J Rheumatol 2018;2018:5217461. [PMID: 29861734 DOI: 10.1155/2018/5217461] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
10 Valim V, Gouvea S, Lima S, Azevedo A, Carvalho A, Pascoal V, Miyamoto S, Souza A, Rocha P, Casagrande T, Balarini L, Serrano E, Duque R, Gavi M, Huber M, Machado K, Dinis V, Caser L, Moura L, Pinto A, Lima A, Salume F, Pinto-neto L, Brandão L, Polito E, Clemente T, Magalhães E, Rodrigues L, Morello F, Oliveira, Thebit M, Bissoli M, Martins-filho O. EFICÁCIA E SEGURANÇA DA VACINAÇÃO ANTI‐AMARÍLICA A CURTO E LONGO PRAZO EM PACIENTES COM DOENÇAS REUMÁTICAS IMUNOMEDIADAS EM TRATAMENTO. Revista Brasileira de Reumatologia 2017;57:S52-3. [DOI: 10.1016/j.rbr.2017.06.092] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
11 Vecchié A, Del Buono MG, Chiabrando GJ, Dentali F, Abbate A, Bonaventura A. Interleukin-1 and the NLRP3 Inflammasome in Pericardial Disease. Curr Cardiol Rep 2021;23:157. [PMID: 34599390 DOI: 10.1007/s11886-021-01589-x] [Reference Citation Analysis]
12 Tam LS, Wei JC, Aggarwal A, Baek HJ, Cheung PP, Chiowchanwisawakit P, Dans L, Gu J, Hagino N, Kishimoto M, Reyes HM, Soroosh S, Stebbings S, Whittle S, Yeap SS, Lau CS. 2018 APLAR axial spondyloarthritis treatment recommendations. Int J Rheum Dis 2019;22:340-56. [PMID: 30816645 DOI: 10.1111/1756-185X.13510] [Cited by in Crossref: 20] [Cited by in F6Publishing: 5] [Article Influence: 6.7] [Reference Citation Analysis]
13 Abboud H, Zheng C, Kar I, Chen CK, Sau C, Serra A. Current and emerging therapeutics for neuromyelitis optica spectrum disorder: Relevance to the COVID-19 pandemic. Mult Scler Relat Disord 2020;44:102249. [PMID: 32526698 DOI: 10.1016/j.msard.2020.102249] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 4.5] [Reference Citation Analysis]